We thus conducted a pilot study to identify differences in SCFA fecal concentrations and SCFA-producing gut bacteria in individuals with normal serum ALT without hepatic steatosis and subjects with persistently high ALT and hepatic steatosis, with and without the influence of obesity. The gene discussed is GPT; the disease is obesity disorder.